vs
BALCHEM CORP（BCPC）与科慕（CC）财务数据对比。点击上方公司名可切换其他公司
科慕的季度营收约是BALCHEM CORP的5.0倍（$1.3B vs $263.6M）。BALCHEM CORP净利率更高（14.9% vs -3.5%，领先18.4%）。BALCHEM CORP同比增速更快（9.8% vs -2.1%）。过去两年BALCHEM CORP的营收复合增速更高（4.9% vs -1.2%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
科慕公司是一家美国化工企业，2015年7月从杜邦分拆成立，总部位于美国特拉华州威尔明顿。公司主营产品包括具备不粘特性的知名品牌特氟龙（聚四氟乙烯PTFE）、二氧化钛以及制冷剂气体，在特种化工领域拥有深厚的技术积累。
BCPC vs CC — 直观对比
营收规模更大
CC
是对方的5.0倍
$263.6M
营收增速更快
BCPC
高出11.9%
-2.1%
净利率更高
BCPC
高出18.4%
-3.5%
两年增速更快
BCPC
近两年复合增速
-1.2%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $263.6M | $1.3B |
| 净利润 | $39.2M | $-47.0M |
| 毛利率 | 35.6% | 11.7% |
| 营业利润率 | 19.8% | — |
| 净利率 | 14.9% | -3.5% |
| 营收同比 | 9.8% | -2.1% |
| 净利润同比 | 16.8% | -261.5% |
| 每股收益（稀释后） | $1.21 | $-0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCCC
| Q4 25 | $263.6M | $1.3B | ||
| Q3 25 | $267.6M | $1.5B | ||
| Q2 25 | $255.5M | $1.6B | ||
| Q1 25 | $250.5M | $1.4B | ||
| Q4 24 | $240.0M | $1.4B | ||
| Q3 24 | $239.9M | $1.5B | ||
| Q2 24 | $234.1M | $1.6B | ||
| Q1 24 | $239.7M | $1.4B |
净利润BCPCCC
| Q4 25 | $39.2M | $-47.0M | ||
| Q3 25 | $40.3M | $46.0M | ||
| Q2 25 | $38.3M | $-380.0M | ||
| Q1 25 | $37.1M | $-5.0M | ||
| Q4 24 | $33.6M | $-13.0M | ||
| Q3 24 | $33.8M | $-32.0M | ||
| Q2 24 | $32.1M | $60.0M | ||
| Q1 24 | $29.0M | $54.0M |
毛利率BCPCCC
| Q4 25 | 35.6% | 11.7% | ||
| Q3 25 | 35.7% | 15.6% | ||
| Q2 25 | 36.4% | 17.2% | ||
| Q1 25 | 35.2% | 17.3% | ||
| Q4 24 | 36.0% | 19.4% | ||
| Q3 24 | 35.6% | 19.0% | ||
| Q2 24 | 35.5% | 19.8% | ||
| Q1 24 | 34.0% | 20.9% |
营业利润率BCPCCC
| Q4 25 | 19.8% | — | ||
| Q3 25 | 20.4% | 2.5% | ||
| Q2 25 | 20.1% | -15.4% | ||
| Q1 25 | 20.4% | — | ||
| Q4 24 | 19.8% | -0.1% | ||
| Q3 24 | 20.0% | -2.1% | ||
| Q2 24 | 19.6% | 4.4% | ||
| Q1 24 | 17.4% | 5.1% |
净利率BCPCCC
| Q4 25 | 14.9% | -3.5% | ||
| Q3 25 | 15.1% | 3.1% | ||
| Q2 25 | 15.0% | -23.5% | ||
| Q1 25 | 14.8% | -0.4% | ||
| Q4 24 | 14.0% | -1.0% | ||
| Q3 24 | 14.1% | -2.1% | ||
| Q2 24 | 13.7% | 3.9% | ||
| Q1 24 | 12.1% | 4.0% |
每股收益（稀释后）BCPCCC
| Q4 25 | $1.21 | $-0.32 | ||
| Q3 25 | $1.24 | $0.31 | ||
| Q2 25 | $1.17 | $-2.53 | ||
| Q1 25 | $1.13 | $-0.03 | ||
| Q4 24 | $1.03 | $-0.07 | ||
| Q3 24 | $1.03 | $-0.22 | ||
| Q2 24 | $0.98 | $0.39 | ||
| Q1 24 | $0.89 | $0.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $670.0M |
| 总债务越低越好 | — | $4.1B |
| 股东权益账面价值 | $1.3B | $250.0M |
| 总资产 | $1.7B | $7.4B |
| 负债/权益比越低杠杆越低 | — | 16.40× |
8季度趋势，按日历期对齐
现金及短期投资BCPCCC
| Q4 25 | $74.6M | $670.0M | ||
| Q3 25 | $65.1M | $613.0M | ||
| Q2 25 | $65.4M | $502.0M | ||
| Q1 25 | $49.9M | $464.0M | ||
| Q4 24 | $49.5M | $713.0M | ||
| Q3 24 | $73.7M | $596.0M | ||
| Q2 24 | $63.7M | $604.0M | ||
| Q1 24 | $60.3M | $746.0M |
总债务BCPCCC
| Q4 25 | — | $4.1B | ||
| Q3 25 | — | $4.1B | ||
| Q2 25 | — | $4.1B | ||
| Q1 25 | — | $4.1B | ||
| Q4 24 | — | $4.1B | ||
| Q3 24 | — | $4.0B | ||
| Q2 24 | — | $4.0B | ||
| Q1 24 | — | $4.0B |
股东权益BCPCCC
| Q4 25 | $1.3B | $250.0M | ||
| Q3 25 | $1.3B | $274.0M | ||
| Q2 25 | $1.3B | $228.0M | ||
| Q1 25 | $1.2B | $566.0M | ||
| Q4 24 | $1.1B | $571.0M | ||
| Q3 24 | $1.2B | $643.0M | ||
| Q2 24 | $1.1B | $714.0M | ||
| Q1 24 | $1.1B | $753.0M |
总资产BCPCCC
| Q4 25 | $1.7B | $7.4B | ||
| Q3 25 | $1.7B | $7.5B | ||
| Q2 25 | $1.7B | $7.5B | ||
| Q1 25 | $1.6B | $7.4B | ||
| Q4 24 | $1.6B | $7.5B | ||
| Q3 24 | $1.6B | $7.5B | ||
| Q2 24 | $1.6B | $7.2B | ||
| Q1 24 | $1.6B | $8.0B |
负债/权益比BCPCCC
| Q4 25 | — | 16.40× | ||
| Q3 25 | — | 14.96× | ||
| Q2 25 | — | 17.99× | ||
| Q1 25 | — | 7.18× | ||
| Q4 24 | — | 7.11× | ||
| Q3 24 | — | 6.20× | ||
| Q2 24 | — | 5.53× | ||
| Q1 24 | — | 5.27× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.3M | $137.0M |
| 自由现金流经营现金流 - 资本支出 | — | $92.0M |
| 自由现金流率自由现金流/营收 | — | 6.9% |
| 资本支出强度资本支出/营收 | — | 3.4% |
| 现金转化率经营现金流/净利润 | 1.72× | — |
| 过去12个月自由现金流最近4个季度 | — | $51.0M |
8季度趋势，按日历期对齐
经营现金流BCPCCC
| Q4 25 | $67.3M | $137.0M | ||
| Q3 25 | $65.6M | $146.0M | ||
| Q2 25 | $47.3M | $93.0M | ||
| Q1 25 | $36.5M | $-112.0M | ||
| Q4 24 | $52.3M | $138.0M | ||
| Q3 24 | $51.3M | $139.0M | ||
| Q2 24 | $45.0M | $-620.0M | ||
| Q1 24 | $33.4M | $-290.0M |
自由现金流BCPCCC
| Q4 25 | — | $92.0M | ||
| Q3 25 | — | $105.0M | ||
| Q2 25 | — | $50.0M | ||
| Q1 25 | — | $-196.0M | ||
| Q4 24 | — | $29.0M | ||
| Q3 24 | — | $63.0M | ||
| Q2 24 | — | $-693.0M | ||
| Q1 24 | — | $-392.0M |
自由现金流率BCPCCC
| Q4 25 | — | 6.9% | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | — | 3.1% | ||
| Q1 25 | — | -14.3% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | — | 4.2% | ||
| Q2 24 | — | -44.6% | ||
| Q1 24 | — | -28.8% |
资本支出强度BCPCCC
| Q4 25 | — | 3.4% | ||
| Q3 25 | — | 2.7% | ||
| Q2 25 | — | 2.7% | ||
| Q1 25 | — | 6.1% | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | — | 5.0% | ||
| Q2 24 | — | 4.7% | ||
| Q1 24 | — | 7.5% |
现金转化率BCPCCC
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | 3.17× | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | -10.33× | ||
| Q1 24 | 1.15× | -5.37× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
CC
| Titanium Technologies | $563.0M | 42% |
| Thermal And Specialized Solutions | $443.0M | 33% |
| Advanced Performance Materials | $312.0M | 23% |
| Other Non-Reportable Segment | $12.0M | 1% |
